Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes

Sponsor
Centre Hospitalier Universitaire Dijon
Study ID
NCT02674893
Phase
PHASE4
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

Study Details

This is an open-label comparative study in three parallel groups. It is expected that 90 patients and/or healthy volunteers will participate in this biomedical research. Distribution in groups * 30 patients with type 2 diabetes and an indication for treatment with a GLP1 analogue (group 1) * 30 patients with type 2 diabetes (control diabetic subjects) not treated with Incretins (group 2) * 30 healthy subjects (non-diabetics) (group 3) This study will investigate modifications in eating behaviour induced by Liraglutide in patients who start treatment with Victoza® and certain aspects, such as liking (hedonic characteristic of a food), wanting (desire to eat a given food) and salivation in response to the presentation of a food by taking measurements at D0 (before initiation of the treatment with Liraglutide in the group concerned) then at 15 days (except for the controls), 3 months and 9 months (only for controls).

Key Dates

Start date
Feb 4, 2014
Status verified
Feb 2026
Primary completion
Aug 31, 2016
Completion
Aug 31, 2016

Study Design

Enrollment
48 participants (actual)
Intervention model
PARALLEL

Arms

  • Experimental: type 2 diabetics treated with GLP1 analogue
  • Active Comparator: Type 2 diabetics not treated with incretins
  • Other: Healthy subjects

Primary Outcome Measure

Modifications in wanting [ Time Frame: Up to 3 months ]

Related Studies